111
Views
14
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

BAL Fluid 8-Isoprostane Concentrations in Eosinophilic Bronchitis and Asthma

, M.D., Ph.D., , M.D., Ph.D., , M.D. & , M.D., Ph.D.
Pages 712-715 | Published online: 09 Sep 2009

References

  • Eder W, Ege M J, von Mutius E. The asthma epidemic. N Engl J Med 2006; 355: 2226–2235
  • Brightling C E, Ward R, Goh K L, Wardlaw A J, Pavord I D. Eosinophilic bronchitis is an important cause of chronic cough. Am J Respir Crit Care Med 1999; 160: 406–410
  • Brightling C E, Symon F A, Birring S S, Bradding P, Wardlaw A J, Pavord I D. Comparison of airway immunopathology of eosinophilic bronchitis and asthma. Thorax 2003; 58: 528–532
  • Lai K F, Chen R C, Liu C L, Luo W, Zhong S Q, He M Z, Li D R, Zhong N S. Etiology and a diagnostic protocol for patients with chronic cough. Zhonghua Jie He He Hu Xi Za Zhi 2006; 29: 96–99
  • Brightling C E, Ward R, Woltmann G, Bradding P, Sheller J R, Dworski R, Pavord I D. Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma. Am J Respir Crit Care Med 2000; 162: 878–882
  • Gibson P G, Zlatic K, Scott J, Sewell W, Woolley K, Saltos N. Chronic cough resembles asthma with IL-5 and granulocyte macrophage colony stimulating factor gene expression in bronchoalveolar cells. J Allergy Clin Immunol 1998; 101: 320–326
  • Sastre B, Fernández-Nieto M, Mollá R, López E, Lahoz C, Sastre J, del Pozo V, Quirce S. Increased prostaglandin E2 levels in the airway of patients with eosinophilic bronchitis. Allergy 2008; 63: 58–66
  • Berry M A, Parker D, Neale N, Woodman L, Morgan A, Monk P, Bradding P, Wardlaw A J, Pavord I D, Brightling C E. Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis. J Allergy Clin Immunol 2004; 114: 1106–1109
  • Park S W, Jangm H K, An M H, Min J W, Jang A S, Lee J H, Park C S. Interleukin-13 and interleukin-5 in induced sputum of eosinophilic bronchitis comparison with asthma. Chest 2005; 128: 1921–1927
  • Caramori G, Papi A. Oxidants and asthma. Thorax 2004; 59: 170–173
  • Roberts L J, Morrow J D. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 2000; 28: 505–513
  • Cracowski J L, Durand T, Bessard G. Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications. Trends Pharmacol Sci 2002; 23: 360–366
  • Morrow J D, Roberts L J. The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease. Am J Respir Crit Care Med 2002; 166: S25–30
  • Wood L G, Fitzgerald D A, Gibson P G, Cooper D M, Garg M L. Lipid peroxidation as determined by plasma isoprostanes is related to disease severity in mild asthma. Lipids 2000; 35: 967–974
  • Baraldi E, Ghiro L, Piovan V, Carraro S, Ciabattoni G, Barnes P J, Montuschi P. Increased exhaled 8-isoprostane in childhood asthma. Chest 2003; 124: 25–31
  • Dworski R, Murray J J, Roberts L J, 2nd, Oates J A, Morrow J D, Fisher L, Sheller J R. Allergen-induced synthesis of F2-isoprostanes in atopic asthmatics. Am J Respir Crit Care Med 1999; 160: 1947–1951
  • Kawikova I, Barnes P J, Takahashi T, Tadjkarimi S, Yacoub M H, Belvisi M G. 8-Epi-PGF2 alpha, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro. Am J Respir Crit Care Med 1996; 153: 590–596
  • Santiago Quirce. Eosinophilic bronchitis in the workplace. Current Opinion in Allergy and Clinical Immunology 2004; 4: 87–91
  • American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225–244
  • Global strategy for asthma management and prevention. 2002, Update from NHLB/WHO Workshop Report 1995. GINA, Revised 2002, NIH Publication No. 02-3659
  • Brightling C E. Chronic cough due to nonasthmatic eosinophilic bronchitis: ACCP evidence-based clinical practice guidelines. Chest 2006; 129: 116S–121S
  • Sovijärvi A R, Malmberg L P, Reinikainen K, Rytilä P, Poppius H. A rapid dosimetric method with controlled tidal breathing for histamine challenge. Repeatability and distribution of bronchial reactivity in a clinical material. Chest 1993; 104: 164–170
  • Pin I, Gibson P G, Kolendowicz R, Girgis-Gabardo A, Denburg J A, Hargreave F E, Dolovich J. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992; 47: 25–29
  • Jackson A S, Sandrini A, Campbell C, Chow S, Thomas P S, Yates D H. Comparison of biomarkers in exhaled breath condensate and bronchoalveolar lavage. Am J Respir Crit Care Med 2007; 175: 222–227
  • Reynolds H Y. Use of bronchoalveolar lavage in humans–past necessity and future imperative. Lung 2000; 178: 271–293
  • Talati M, Meyrick B, Peebles R S, Jr, Davies S S, Dworski R, Mernaugh R, Mitchell D, Boothby M, Roberts L J, 2nd, Sheller J R. Oxidant stress modulates murine allergic airway responses. Free Radic Biol Med 2006; 40: 1210–1219
  • Katsumata U, Miura M, Ichinose M, Kimura K, Takahashi T, Inoue H, Takishima T. Oxygen radicals produce airway constriction and hyperresponsiveness in anesthetized cats. Am Rev Respir Dis 1990; 141: 1158–1161
  • Weiss E B, Bellino J R. Leukotriene-associated toxic oxygen metabolites induces airway hyperreactivity. Chest 1986; 89: 709–716
  • Rhoden K J, Barnes P J. Effect of hydrogen peroxide on guinea-pig tracheal muscle in vitro: role of cyclooxygenase and airway epithelium. Br J Pharmacol 1989; 98: 325–330
  • Barnes B J. Reactive oxygen species and airway inflammation. Free Radic Biol Med 1990; 9: 235–243
  • Kanazawa H, Kurihara N, Hirata K, Takeda T. The role of free radicals in airway obstruction in asthmatic patients. Chest 1991; 100: 1319–1322
  • Sedgwick J B, Geiger K M, Busse W W. Superoxide generation by hypodense eosinophils from patients with asthma. Am Rev Respir Dis 1990; 142: 120–125
  • Joseph B Z, Routes J M, Borish L. Activities of superoxide dismutases and NADPH oxidase in neutrophils obtained from asthmatic and normal donors. Inflammation 1993; 17: 361–367
  • Wood L G, Gibson P G, Garg M L. Biomarkers of lipid peroxidation, airway inflammation and asthma. Eur Respir J 2003; 21: 177–186
  • Mortaz E, Redegeld F A, Nijkamp F P, Engels F. Aspirin induces the production of the inflammatory mediator 8-epi-PGF in mast cells. Eur J Pharmacol 2006; 543: 190–193
  • Janssen L J, Catalli A, Helli P. The pulmonary biology of isoprostanes. Antioxid Redox Signal 2005; 7: 244–255
  • Held H D, Uhlig S. Mechanisms of endotoxin-induced airway and pulmonary vascular hyperreactivity in mice. Am J Respir Crit Care Med 2000; 162: 1547–1552
  • Okazawa A, Kawikova I, Cui Z H, et al. 8-epi-PGF2alpha induces airflow obstruction and airway plasma exudation in vivo. Am J Respir Crit Care Med 1997; 155: 436–441

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.